These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
672 related articles for article (PubMed ID: 24354621)
21. Diagnosis of focal liver lesions with gadoxetic acid-enhanced MRI: is a shortened delay time possible by adding diffusion-weighted imaging? Kim MY; Kim YK; Park HJ; Park MJ; Lee WJ; Choi D J Magn Reson Imaging; 2014 Jan; 39(1):31-41. PubMed ID: 24115329 [TBL] [Abstract][Full Text] [Related]
22. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157 [TBL] [Abstract][Full Text] [Related]
23. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. Kim SH; Kim SH; Lee J; Kim MJ; Jeon YH; Park Y; Choi D; Lee WJ; Lim HK AJR Am J Roentgenol; 2009 Jun; 192(6):1675-81. PubMed ID: 19457834 [TBL] [Abstract][Full Text] [Related]
24. Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma. Kim YK; Kim CS; Han YM; Park G; Hwang SB; Yu HC Clin Radiol; 2010 May; 65(5):358-65. PubMed ID: 20380933 [TBL] [Abstract][Full Text] [Related]
25. Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation. Nishie A; Kakihara D; Asayama Y; Ushijima Y; Takayama Y; Fujita N; Shimamoto D; Shirabe K; Hida T; Honda H Clin Radiol; 2015 Mar; 70(3):254-61. PubMed ID: 25522901 [TBL] [Abstract][Full Text] [Related]
26. Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma. Ooka Y; Kanai F; Okabe S; Ueda T; Shimofusa R; Ogasawara S; Chiba T; Sato Y; Yoshikawa M; Yokosuka O Magn Reson Imaging; 2013 Jun; 31(5):748-54. PubMed ID: 23218794 [TBL] [Abstract][Full Text] [Related]
27. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319 [TBL] [Abstract][Full Text] [Related]
28. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases. Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068 [TBL] [Abstract][Full Text] [Related]
29. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. Jang KM; Kim SH; Kim YK; Choi D Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304 [TBL] [Abstract][Full Text] [Related]
30. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation. Park MJ; Kim YK; Lim S; Rhim H; Lee WJ Radiology; 2014 Mar; 270(3):768-76. PubMed ID: 24475800 [TBL] [Abstract][Full Text] [Related]
31. Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study. Tsurusaki M; Sofue K; Isoda H; Okada M; Kitajima K; Murakami T J Gastroenterol; 2016 Jan; 51(1):71-9. PubMed ID: 26130441 [TBL] [Abstract][Full Text] [Related]
32. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods. Holzapfel K; Eiber MJ; Fingerle AA; Bruegel M; Rummeny EJ; Gaa J Abdom Imaging; 2012 Feb; 37(1):74-82. PubMed ID: 21597893 [TBL] [Abstract][Full Text] [Related]
33. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092 [TBL] [Abstract][Full Text] [Related]
34. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging? Kim YK; Kim CS; Han YM; Park G Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488 [TBL] [Abstract][Full Text] [Related]
35. Ferucarbotran-enhanced magnetic resonance imaging versus gadoxetic acid-enhanced magnetic resonance imaging for the preoperative detection of hepatocellular carcinoma: initial experience. Lee JY; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ J Comput Assist Tomogr; 2010 Jan; 34(1):127-34. PubMed ID: 20118735 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. Marks RM; Ryan A; Heba ER; Tang A; Wolfson TJ; Gamst AC; Sirlin CB; Bashir MR AJR Am J Roentgenol; 2015 Mar; 204(3):527-35. PubMed ID: 25714281 [TBL] [Abstract][Full Text] [Related]
37. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases. Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713 [TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy? Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276 [TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT. Baek CK; Choi JY; Kim KA; Park MS; Lim JS; Chung YE; Kim MJ; Kim KW Clin Radiol; 2012 Feb; 67(2):148-56. PubMed ID: 21920517 [TBL] [Abstract][Full Text] [Related]
40. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]